Emeritus Professor Sian Harding is a cardiovascular scientist and Emeritus Professor at Imperial College London, where her research has focused on heart failure, cardiac physiology and the biology of the failing heart. She is a Fellow of the Academy of Medical Sciences and a leading voice on sex differences in cardiovascular disease.
Scientific reviewers and partners
We are grateful to our scientific reviewers and partners for their commitment and support to realise our mission to reinvent medicine based on biological sex.
Dr Berna Özdemir is a Senior Consultant and Senior Lecturer in Medical Oncology at Bern University Hospital, Switzerland, specialised in precision oncology and immuno-oncology. She is a Founding Member of the ESMO Gender Medicine Taskforce and an internationally recognized expert focused on integrating sex and gender into oncology research and clinical practice.
Dr Miriam Wiestler is a gastroenterologist at Hannover Medical School, Germany, with clinical and research expertise in inflammatory bowel disease. Her work addresses sex-specific patterns in IBD diagnosis, disease course, and treatment response.
Dr Kate Womersley is a psychiatrist and a Research Fellow at The George Institute for Global Health at Imperial, where her Wellcome-funded work focuses on embedding sex and gender research into biomedical research policy. She is Co-Principal Investigator of the MESSAGE project, which has successfully established sex and gender requirements across major UK research funders including NIHR and Wellcome. Her writing on medicine and women’s health can be found in The Lancet, The Guardian and The Financial Times.
Dr Shirin Heidari is a Senior Researcher at the Gender Center, Geneva Graduate Institute, and Founding President of GENDRO, an international organisation advancing gender-responsive research and data analysis. She is the lead author of the Sex and Gender Equity in Research (SAGER) guidelines – the research and reporting framework cited throughout this paper.
“Awareness of sex differences started in cardiovascular disease. Now we know they go so much further. This is an important paper which not only explains why but shows us the way to go. Excited to be part of what comes next.”
Partners
The Salve Health Ltd who sense-checked checked our references and edited The Sex Factor Manuscript. They have been long-term champions of The SAGER guidelines and have published their own research onto sex-disaggregated data of medicines.
TwentyeightC who have generously created the visual identity and white paper design for The Sex Factor.
Uptitude a company dedicated to solving data problems. Uptitude is our partner for The Sex Factor Index, coming soon!
Create Health who are huge supporters of our work and have generously helped us with artwork and print.
Shape who have supported and empowered us to build our own website!